Akcea Therapeutics Inc (AKCA) Inventory Turnover Ratio, from second quarter 2020 to second quarter 2019, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Akcea Therapeutics Inc   (NASDAQ: AKCA)
 

Akcea Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2020, Akcea Therapeutics Inc 's inventory turnover ratio sequentially decreased to 0.89 in the second quarter 2020, unsurprisingly, as the Akcea Therapeutics Inc markets continue to deteriorate, and AKCA's faces growing challenges to bring down its inventories. Akcea Therapeutics Inc 's average inventory processing period in the Jun 30 2020 quarter, has increased to 410 days, from 250 days, in the Mar 31 2020 quarter.

Within Healthcare sector 351 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1839 in the first quarter 2020, to 1951.

AKCA Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Akcea Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AKCA Inventory Turnover Ratio (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter
Y / Y Inventory Growth 66.01 % - 10272.94 % - -
Y / Y Cost of Sales Growth -75.48 % 95.7 % -28.73 % 242.51 % -
Inventory Turnover Ratio (TTM) 0.89 1.46 1.87 2.97 5.23
AKCA's Total Ranking # 1951 # 1839 # 1955 # 1950 # 0
Average inventory processing period 409 250 195 123 70
Seq. Inventory Growth 0.24 % 55.64 % 2.04 % 4.28 % -
Seq. Cost of Sales Growth -70.35 % 233.54 % -40.27 % -58.48 % 136.62 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 113
Healthcare Sector # 352
Overall Market # 1951

Inventory Turnover Ratio Statistics
High Average Low
1.46 1.18 0.89
(Mar 31 2020)   (Jun 30 2020)



AKCA Company Profile >> Back to AKCA Efficiency Comparisons >> Compare AKCA Inventory Turnover Ratio to its Competitors

Financial Statements
Akcea Therapeutics Inc 's Inventories $ 14 Millions Visit AKCA's Balance sheet
Akcea Therapeutics Inc 's Cost of Revenues TTM $ 10 Millions Visit AKCA's Income Statement
What are AKCA's Sales? Visit AKCA's Sales by Segment

Other Inventory Turnover Ratios
Akcea Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
AKCA's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for AKCA's Competitors
Inventory Turnover Ratio for AKCA's Suppliers
Inventory Turnover Ratio for AKCA's Customers

You may also want to know
AKCA's Sales Growth Rates AKCA's Pe Price to earnings ratio AKCA's Receivables Turnover Ratio AKCA's Stock Quote
AKCA's Net Income Growth Rates AKCA's Ps Price to Sales ratio AKCA's Sales per Employee AKCA's Asset Turnover Ratio
AKCA's Net Margin AKCA's Pb Price to Book ratio AKCA's Financial Strength Ratios AKCA's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2020, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2020 Inventories at quarter ending Jun 30 2020
Teva Pharmaceutical Industries Limited  2.00 $ 8,869.000  Millions$ 4,427  Millions
Sorrento Therapeutics Inc   2.00 $ 6.581  Millions$ 3  Millions
Apollo Endosurgery inc   1.98 $ 20.276  Millions$ 10  Millions
Chembio Diagnostics Inc   1.95 $ 20.976  Millions$ 11  Millions
Luminex Corporation  1.94 $ 157.385  Millions$ 81  Millions
Atricure Inc   1.93 $ 58.875  Millions$ 31  Millions
Bausch Health Companies Inc   1.91 $ 2,180.000  Millions$ 1,139  Millions
Emergent Biosolutions Inc   1.91 $ 447.600  Millions$ 234  Millions
Strongbridge Biopharma plc  1.90 $ 3.349  Millions$ 2  Millions
Endologix Inc  1.88 $ 50.689  Millions$ 27  Millions
Acadia Pharmaceuticals Inc   1.88 $ 11.134  Millions$ 6  Millions
Inspire Medical Systems inc   1.87 $ 12.946  Millions$ 7  Millions
Procyon Corporation  1.86 $ 1.135  Millions$ 1  Millions
Haemonetics Corporation  1.83 $ 486.968  Millions$ 266  Millions
Viewray Inc   1.82 $ 72.314  Millions$ 40  Millions
Yunhong Green Cti Ltd   1.82 $ 24.505  Millions$ 13  Millions
Amphastar Pharmaceuticals Inc   1.80 $ 195.381  Millions$ 108  Millions
Silk Road Medical Inc   1.80 $ 19.477  Millions$ 11  Millions
Bio rad Laboratories Inc   1.80 $ 1,045.764  Millions$ 582  Millions
Accuray Incorporated  1.79 $ 233.207  Millions$ 130  Millions
Sensus Healthcare Inc   1.79 $ 6.563  Millions$ 4  Millions
Cv Sciences Inc   1.79 $ 16.689  Millions$ 9  Millions
Lakeland Industries Inc   1.78 $ 76.848  Millions$ 43  Millions
Kindred Biosciences Inc   1.77 $ 4.266  Millions$ 2  Millions
Nabriva Therapeutics Plc  1.76 $ 0.446  Millions$ 0  Millions
Nanomix Corp  1.76 $ 0.007  Millions$ 0  Millions
Aerie Pharmaceuticals Inc   1.75 $ 32.805  Millions$ 19  Millions
Sunwin Stevia International Inc.  1.75 $ 22.796  Millions$ 13  Millions
Pacira Biosciences inc   1.74 $ 106.245  Millions$ 61  Millions
Cerus Corporation  1.73 $ 34.901  Millions$ 20  Millions

Date modified: 2026-08-29T17:40:54+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.